{
    "title": "Astrazeneca's US Covid trial to resume after regulators fail to link patient's illness with the vaccine",
    "url": "https://www.dailymail.co.uk/money/markets/article-8860625/Astrazenecas-Covid-vaccine-trial-resume.html",
    "date": "2020-10-20",
    "keywords": [
        "trial",
        "fda",
        "share",
        "fund",
        "hold",
        "vaccine",
        "drug",
        "draft",
        "letter",
        "investment",
        "account",
        "fee",
        "latestage",
        "covid19",
        "week",
        "food",
        "administration",
        "illnessthe",
        "participant",
        "uk",
        "inflammatory",
        "disorder",
        "information",
        "incident",
        "housebuilder",
        "bellway",
        "dividend",
        "stamp",
        "duty",
        "brummer",
        "google",
        "reboot",
        "founder",
        "peter",
        "voice",
        "cash",
        "article",
        "illness",
        "evidence",
        "part",
        "analysis",
        "vaccination",
        "content",
        "decision",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}